KLP Kapitalforvaltning’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$130K Hold
10,900
– – ﹤0.01% 2007
2026
Q2
$264K Buy
10,900
+4,100
+60% +$77.5K ﹤0.01% 1786
2026
Q1
$112K Buy
+6,800
New +$130K ﹤0.01% 2022

Other funds holding GLUE

KLP Kapitalforvaltning's GLUE Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Monte Rosa Therapeutics (GLUE) position steady in Q3 2026 at 10,900 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2007.

KLP Kapitalforvaltning first reported a position in GLUE in Q1 2026 and has held it in 3 quarters since. The position peaked at $264K in Q2 2026. 190 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.

  • KLP Kapitalforvaltning held 10,900 shares of Monte Rosa Therapeutics worth $130K as of Q3 2026.
  • KLP Kapitalforvaltning left its Monte Rosa Therapeutics share count unchanged in Q3 2026.
  • Monte Rosa Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #2007 holding.
  • KLP Kapitalforvaltning first reported a position in Monte Rosa Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • KLP Kapitalforvaltning's Monte Rosa Therapeutics position peaked at $264K in Q2 2026.
  • 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.